Cargando…

Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?

Detalles Bibliográficos
Autores principales: Metges, J-P, Gibault, L, Conan-Charlet, V, Lozac'H, P, Robaszkiewicz, M, Bessaguet, C, Lagarde, N, Volant, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361253/
http://dx.doi.org/10.1038/sj.bjc.6603081
_version_ 1782153170934300672
author Metges, J-P
Gibault, L
Conan-Charlet, V
Lozac'H, P
Robaszkiewicz, M
Bessaguet, C
Lagarde, N
Volant, A
author_facet Metges, J-P
Gibault, L
Conan-Charlet, V
Lozac'H, P
Robaszkiewicz, M
Bessaguet, C
Lagarde, N
Volant, A
author_sort Metges, J-P
collection PubMed
description
format Text
id pubmed-2361253
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23612532009-09-10 Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus? Metges, J-P Gibault, L Conan-Charlet, V Lozac'H, P Robaszkiewicz, M Bessaguet, C Lagarde, N Volant, A Br J Cancer Letter to the Editor Nature Publishing Group 2006-04-24 2006-04-18 /pmc/articles/PMC2361253/ http://dx.doi.org/10.1038/sj.bjc.6603081 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Metges, J-P
Gibault, L
Conan-Charlet, V
Lozac'H, P
Robaszkiewicz, M
Bessaguet, C
Lagarde, N
Volant, A
Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
title Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
title_full Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
title_fullStr Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
title_full_unstemmed Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
title_short Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
title_sort reply: her2 (erbb2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361253/
http://dx.doi.org/10.1038/sj.bjc.6603081
work_keys_str_mv AT metgesjp replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT gibaultl replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT conancharletv replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT lozachp replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT robaszkiewiczm replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT bessaguetc replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT lagarden replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus
AT volanta replyher2erbb2receptorsapotentialtherapeutictargetinsquamouscellcarcinomaofoesophagus